SCHEMBL5899359

SCHEMBL5899359

O=C(O)/C(O)=C/C(=O)c1ccn(S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.62
TUBB4A P04350 2/20 0.49
TUBB P07437 2/20 0.49
TUBA3C P0DPH7 2/20 0.49
TUBA1B P68363 2/20 0.49
TUBA4A P68366 2/20 0.49
TUBB4B P68371 2/20 0.49
TUBB3 Q13509 2/20 0.49
TUBB2A Q13885 2/20 0.49
TUBB8 Q3ZCM7 2/20 0.49
TUBA3E Q6PEY2 2/20 0.49
TUBA1A Q71U36 2/20 0.49
TUBA1C Q9BQE3 2/20 0.49
TUBB6 Q9BUF5 2/20 0.49
TUBB2B Q9BVA1 2/20 0.49
TUBB1 Q9H4B7 2/20 0.49
HDAC6 Q9UBN7 2/20 0.47
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899360 1.00 PKM (0.62) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4677987 0.88 ALDH1A1 (0.63) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4677989 0.88 ALDH1A1 (0.63) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4676800 0.88 PKM (0.48) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4676797 0.88 PKM (0.48) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1366438 0.77 PKM (1.00) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4671799 0.75 GRM4 (0.37) PKMALDH1A1KLKB1GRM4PARL
SCHEMBL9590857 0.75 PKM (0.68) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5977847 0.74 PKM (0.62) PKMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4781263 0.74 PKM (0.70) PKMTUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 PKM 2609/4885TUBB4A 786/4885TUBB 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.